Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States CRS memo addresses hemp industry issues in Farm Bill…
  • United States SAFER Banking Act unlikely to be included in end-of-year legislation…
  • Germany Proposed amendment with further changes to Cannabis Act leaked to press…
  • South Africa Call for submissions on Cannabis for Private Purposes Bill…
  • New Hampshire - United States No further forward on how to regulate recreational cannabis…
  • Australia Victoria open to discuss decriminalisation of personal use…
  • Brazil Public hearing tomorrow on regulation of cannabis/hemp production…
  • Germany Product alert bans sales of e-cig containing cannibinoids…
  • New York - United States CAURD lawsuit settlement may allow cannabis dispensaries to open …
  • United States USDA revokes hemp licences from farmers who also grow cannabis…
  • Germany Bundestag agrees on Cannabis Bill amendments…
  • Malta NGOs call for additional measures to protect children from cannabis…
View all
News analysis

A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill

Written by || 30th December 2022 || News analysis | Cannabinoids | Cannabis – medical | Cannabis – recreational | Regulation and legislation | GeographiesAfrica Asia Colombia Europe Germany Morocco North America South America Thailand United States

This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids. Concerns around CBD, typically considered the “safest” cannabinoid and the one derived from widely legal hemp, have only increased. Whereas concerns over cannabis itself continue to be minimised as more and more jurisdictions come to support it for medical and even recreational purposes.

Sometimes, confusingly, this has even been happening in the same countries.

Read full article

Download the full news analysis

“A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill”








    I'm already a subscriber

    Login

    Author default picture

    Freddie Dawson

    Our Key Benefits

    The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

    Thanks for getting in touch with us

    Please leave your enquiry and we will get back to you within 24 hours


      Sign up to our newsletter

      Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


        See more


        By signing up you agree to our Privacy Policy.